• Home
  • Shanghai GenAIwings Biotechnology Co., Ltd.
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 12F54
Book a meeting

Shanghai GenAIwings Biotechnology Co., Ltd.

About Shanghai GenAIwings Biotechnology Co., Ltd.

GenAIwings started providing enzyme solutions in 2021, with the aim of being the pioneer in providing enzyme solutions. Our core value is "Technology Leads the Innovation", and we are dedicated to advancing the industrial upgradation and product innovation via combining the AI technology with the enzyme R&D process. Our product portfolio covers biopharma, food and nutrition, at the core of an AI-enabled model, from strain design and construction, process development and validation, to the commercial scale-up. We have an ISO90001-compliant facility and manufacturing base. Our product series includes Recombinant Ente...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 12F54
  • Country/Region:
    China
  • Founded:
    2025
  • On CPHI since:
    2026
  • Employees:
    50 - 99
Company types
Contract Research Organisation (CRO)
Contact info
  • 0354-6638277
  • Website
  • 16th Floor, Building 1, No. 58 Yuanmei Road, 00, Shanghai, Shanghai, China
Show contact info Hide contact info

Products from Shanghai GenAIwings Biotechnology Co., Ltd. (3)

  • Nexligos™ Protein A ME

    Product Nexligos™ Protein A ME

    GenAIwings leveraged the MatwingsVenus™ protein design large model to engineer and optimize Protein A, elevating its elution pH to 5.0 and effectively addressing the purification challenges of low‑pH‑sensitive antibodies. This Gentle Elution Protein A significantly reduces antibody aggregation caused by lo...
  • Nexligos™ Protein A Pan Alkali

    Product Nexligos™ Protein A Pan Alkali

    GenAIwings利用MatwingsVenus™蛋白质设计大型模型提升了蛋白质A的碱性耐受性。该产物以大肠杆菌表达，通过色谱纯化，纯度达到≥95%。纯化过程不采用抗体柱亲和色谱，从而消除了最终产物中无关的IgG污染风险。
  • Semaglutide Intermediate P29

    Product Semaglutide Intermediate P29

    司美格鲁肽是一种长效胰高血糖素样肽-1（GLP-1）受体激动剂，广泛应用于2型糖尿病和肥胖的管理。29个氨基酸主链中间体是semaglutide合成的关键原料，直接影响后续修饰、纯化和大规模生产的质量。这种中间体可以通过化学合成或发酵制备;本文所述的产品是通过发酵制造的。